Results 81 to 90 of about 1,634,991 (251)
One hundred fifty-four patients with artificial pacemaker (АРМ) and diagnosed CHD with effort angina, functional class II-IV, were included into the trial. The influence of electrocardiostimulation (ECS) on CHD clinic was surveyed.
B. G. Iskenderov+2 more
doaj
Atrial fibrillation (AF) was observed in almost half of patients with insertable cardiac monitor and symptomatic heart failure (HF). One‐fourth of the patients had new onset AF and a higher rate of HF events compared with patients without AF. AF incidence was similar in HF patients with preserved versus reduced left ventricular ejection fraction ...
Muhammad Shahzeb Khan+8 more
wiley +1 more source
Abstract Aims Mortality risk after hospitalization for heart failure (HF) is high, especially in the first 90 days. This study aimed to construct a model automatically predicting 90 day post‐discharge mortality using electronic health record (EHR) data 48 h after admission and artificial intelligence. Methods All HF‐related admissions from 2015 to 2020
Joconde Weller+12 more
wiley +1 more source
Superior vena cava (SVC) syndrome is typically dramatic. Although the diagnosis is usually easy, elucidation of the etiology is difficult. We present a patient who developed SVC syndrome early after transvenous pacemaker implantation and who was ...
Liting Pan+3 more
doaj
INDICACIONES DE ESTIMULACIÓN ELÉCTRICA TRANSITORIA, COMPLICACIONES Y NECESIDAD DE ESTIMULACIÓN CARDÍACA PERMANENTE / Use of temporary cardiac pacing, its complications and need for permanent cardiac pacing [PDF]
Resumen: Introducción: La estimulación cardíaca temporal está indicada en diversas situaciones de extrema urgencia, en pacientes con bradiarritmias graves y bloqueos aurículo-ventriculares de II o III grados.Su indicación siempre se considera ante la ...
Humberto Ramos González+5 more
doaj
Analysis of Heterogeneous Cardiac Pacemaker Tissue Models and Traveling Wave Dynamics [PDF]
The sinoatrial-node (SAN) is a complex heterogeneous tissue that generates a stable rhythm in healthy hearts, yet a general mechanistic explanation for when and how this tissue remains stable is lacking. Although computational and theoretical analyses could elucidate these phenomena, such methods have rarely been used in realistic (large-dimensional ...
arxiv
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt+15 more
wiley +1 more source
New Insights into Pacing Induced Cardiomyopathy
Pacing induced cardiomyopathy (PICM) can occur as a complication due to pacing the right ventricle. Its precise definition varies across different studies, leading to uncertainty as to the best approach for managing this entity. More than 10% of patients
Sung Soo Kim, Hyung Wook Park
doaj +1 more source
Comparison of Benefits from Cardiac Resynchronization Therapy between Patients with Ischemic Cardiomyopathy and Patients with Idiopathic Dilated Cardiomyopathy [PDF]
Background: Cardiac resynchronization therapy (CRT) is an effective treatment for patients with moderate to severe heart failure. However, 20-30% of patients remain non-responders to CRT.
Talia Alenabi+15 more
doaj +2 more sources